Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

New Strategies from Natural Materials to Fight against Diet-induced Metabolic Disorders (Part - II)

Author(s): Mallikarjuna Korivi and Betty R. Liu

Volume 27, Issue 6, 2021

Published on: 22 February, 2021

Page: [761 - 762] Pages: 2

DOI: 10.2174/138161282706210222144912

Abstract

According to the global statistics, the incidence of metabolic syndrome (MetS), which is a multifactorial disease with multiple risk factors, has reached nearly one-quarter of the population, and poses a serious threat to public health. MetS is a cluster of conditions characterized by insulin resistance, hypertension, obesity, and cardiovascular-related risk factors. Various aspects, such as modern lifestyle (diet, sedentary behavior), aging and genes attribute to increasing the morbidity of MetS. While external interventions, prescribed drugs and natural materials play an indispensable role in the management of MetS. Intake of plant-based bioactive compounds and peptide-based drug delivery systems emerge as safe and effective pharmacological approaches to treat MetS complications. Natural biomaterials are able to decrease the adverse effects of drugs and enhance treatment efficiency. In this thematic issue, we explored the beneficial effects of various phytochemicals, marine drugs and cellpenetrating peptides (CPPs)-mediated drug delivery system in the management of MetS and associated disorders. The usage of CPPs in combination with other therapeutic agents like nanoparticles and peptides is a novel and efficient approach to conquer the components in MetS.

Keywords: Nature products, marine drugs, diabetes, drug delivery system, cell-penetrating peptides, metabolic syndrome (MetS).

Next »
[1]
Jena AB, Kanungo N, Nayak V, Chainy GBN, Dandapat J. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep 2021; 11(1): 2043.
[2]
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available at:. https://covid19.who.int/
[3]
Korivi M, Liu BR. Novel and practical approaches to manage diet-induced metabolic disorders: Part-I. Curr Pharm Des 2020; 26(39): 4953-4.
[4]
Shanmugam KR, Shanmugam B, Venkatasubbaiah G, Ravi S, Reddy KS. Medicinal Plants and Bioactive Compounds for Diabetes Management: Important Advances in Drug Discovery. Current Pharmaceutical Design 2021; 27(6): 749-60.
[5]
International Diabetes Federation Diabetes Atlas. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation 2019.
[6]
World Health Organization. The top 10 causes of death Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
[7]
Alamdari NM, Rahimi FS, Afaghi S, et al. The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients. Diab Metabol Syn Clin Res Rev 2020; 14(6): 1979-86.
[8]
Liu Y, Ye W, Chen Q, Zhang Y, Kuo C-H, Korivi M. Resistance Exercise Intensity is Correlated with Attenuation of HbA1c and Insulin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2019; 16(1): 140.
[9]
Korivi M, Huang Y-W, Liu BR. Cell-Penetrating Peptides as a Potential Drug Delivery System for Effective Treatment of Diabetes. Curr Pharm Des 2021; 27(6): 802-11.
[10]
Khalivulla SI, Mohammed A, Mallikarjuna K. Novel Phytochemical Constituents and their Potential to Manage Diabetes. Curr Pharm Des 2021; 27(6): 761-74.
[11]
Rayapu L, Chakraborty K, Valluru L. Marine Algae as a Potential Source for Anti-diabetic Compounds - A Brief Review. Curr Pharm Des 2021; 27(6): 775-88.
[12]
Sridevi V, Naveen P, Karnam VS, Reddy PR, Arifullah M. Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-Based Diet. Curr Pharm Des 2021; 27(6): 788-801.

© 2024 Bentham Science Publishers | Privacy Policy